These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33717255)

  • 21. Regenerative Medicine-Based Treatment for Vitiligo: An Overview.
    Bellei B; Papaccio F; Picardo M
    Biomedicines; 2022 Oct; 10(11):. PubMed ID: 36359263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo.
    You S; Cho YH; Byun JS; Shin EC
    Clin Exp Immunol; 2013 Oct; 174(1):38-44. PubMed ID: 23711243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beyond skin white spots: Vitiligo and associated comorbidities.
    Hu Z; Wang T
    Front Med (Lausanne); 2023; 10():1072837. PubMed ID: 36910477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of miRNA-21-5p in vitiligo patients and effects of miRNA-21-5p on SOX5, beta-catenin, CDK2 and MITF protein expression in normal human melanocytes.
    Aguennouz M; Guarneri F; Oteri R; Polito F; Giuffrida R; Cannavò SP
    J Dermatol Sci; 2021 Jan; 101(1):22-29. PubMed ID: 33176966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo.
    Eby JM; Kang HK; Tully ST; Bindeman WE; Peiffer DS; Chatterjee S; Mehrotra S; Le Poole IC
    J Invest Dermatol; 2015 Jun; 135(6):1574-1580. PubMed ID: 25634358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.
    Webb KC; Eby JM; Hariharan V; Hernandez C; Luiten RM; Le Poole IC
    Exp Dermatol; 2014 Aug; 23(8):529-33. PubMed ID: 24840876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the etiology of contact/occupational vitiligo.
    Boissy RE; Manga P
    Pigment Cell Res; 2004 Jun; 17(3):208-14. PubMed ID: 15140065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of Monobenzone-Induced Vitiligo Mouse Model by the Addition of Chronic Stress.
    Dong J; Lai Y; Zhang X; Yue Y; Zhong H; Shang J
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular changes of non-segmental vitiligo: A case-control study.
    Ezzeldine SM; Hasan MS; Abdelmaksoud GI; Ibrahim EN; Rageh MA
    Australas J Dermatol; 2022 Nov; 63(4):e305-e311. PubMed ID: 35971248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitiligo.
    Picardo M; Dell'Anna ML; Ezzedine K; Hamzavi I; Harris JE; Parsad D; Taieb A
    Nat Rev Dis Primers; 2015 Jun; 1():15011. PubMed ID: 27189851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune response against tyrosinase induces depigmentation in C57BL/6 black mice.
    Al Robaee AA; Alzolibani AA; Rasheed Z
    Autoimmunity; 2020 Dec; 53(8):459-466. PubMed ID: 33084421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cultured Epidermal Melanocyte Transplantation in Vitiligo: A Review Article.
    Zokaei S; Farhud DD; Keykhaei M; Zarif Yeganeh M; Rahimi H; Moravvej H
    Iran J Public Health; 2019 Mar; 48(3):388-399. PubMed ID: 31223565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current Concepts of Vitiligo Immunopathogenesis.
    Hlača N; Žagar T; Kaštelan M; Brajac I; Prpić-Massari L
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanocytes and keratinocytes morphological changes in vitiligo patients. A histological, immunohistochemical and ultrastructural analysis.
    Elsherif R; Mahmoud WA; Mohamed RR
    Ultrastruct Pathol; 2022 Mar; 46(2):217-235. PubMed ID: 35243959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deciphering skin re-pigmentation patterns in vitiligo: an update on the cellular and molecular events involved.
    Lei TC; Hearing VJ
    Chin Med J (Engl); 2020 May; 133(10):1231-1238. PubMed ID: 32433056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs: Emerging players in the pathogenesis of vitiligo.
    Yu X; Cui Y; Zhu X; Xu H; Li L; Gao G
    Front Cell Dev Biol; 2022; 10():964982. PubMed ID: 36187493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes.
    Shajil EM; Chatterjee S; Agrawal D; Bagchi T; Begum R
    Indian J Exp Biol; 2006 Jul; 44(7):526-39. PubMed ID: 16872041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitiligo.
    Dunn JF
    Am Fam Physician; 1986 May; 33(5):137-43. PubMed ID: 3706094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in the melanosome distribution within the epidermal melanin units and its association with the impairing background of leukoderma in vitiligo and halo nevi: a retrospective study.
    Xiong XX; Ding GZ; Zhao WE; Li X; Ling YT; Sun L; Gong QL; Lu Y
    Arch Dermatol Res; 2017 Jul; 309(5):323-333. PubMed ID: 28314912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis in feathers of Smyth line chickens with autoimmune vitiligo.
    Wang X; Erf GF
    J Autoimmun; 2004 Feb; 22(1):21-30. PubMed ID: 14709410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.